APA (7th ed.) Citation

Ergül, R. B., Gürlek, I. T., Yitgin, Y., Ozcan, S. G., Özervarlı, M. F., Turan, S., . . . Tefik, T. (2026). Pharmacovigilance analysis and real-world adverse event profile (safety signals and product-related issues) of potassium citrate: A US FDA adverse event reporting system (FAERS) based analysis. Urolithiasis, 54(1), 1. https://doi.org/10.1007/s00240-026-01989-0

Chicago Style (17th ed.) Citation

Ergül, Rifat Burak, et al. "Pharmacovigilance Analysis and Real-world Adverse Event Profile (safety Signals and Product-related Issues) of Potassium Citrate: A US FDA Adverse Event Reporting System (FAERS) Based Analysis." Urolithiasis 54, no. 1 (2026): 1. https://doi.org/10.1007/s00240-026-01989-0.

MLA (9th ed.) Citation

Ergül, Rifat Burak, et al. "Pharmacovigilance Analysis and Real-world Adverse Event Profile (safety Signals and Product-related Issues) of Potassium Citrate: A US FDA Adverse Event Reporting System (FAERS) Based Analysis." Urolithiasis, vol. 54, no. 1, 2026, p. 1, https://doi.org/10.1007/s00240-026-01989-0.